Sean N. Prater

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease

Suhrad G. Banugaria, Sean N. Prater, Yiu-Ki Ng et al. · Genetics in Medicine · 2011 · 251 citations · Full text

Pharmacy, Immunology, Pediatrics +15

The emerging phenotype of long-term survivors with infantile Pompe disease

Sean N. Prater, Suhrad G. Banugaria, Stephanie DeArmey et al. · Genetics in Medicine · 2012 · 191 citations

Life Sciences, Neuroscience, Pediatrics +4

Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT

Suhrad G. Banugaria, Sean N. Prater, Trusha Patel et al. · PLoS ONE · 2013 · 110 citations · Full text

Life Sciences, Immunology, Pediatrics +17

Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

Suhrad G. Banugaria, Sean N. Prater, Judeth K. McGann et al. · Genetics in Medicine · 2012 · 86 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy

Sean N. Prater, Trusha Patel, Anne F. Buckley et al. · Orphanet Journal of Rare Diseases · 2013 · 82 citations · Full text

Life Sciences, Pathobiology, Pathology +17